View of Serum hBD-2, IL-36γ, CCL20/MIP-3α, and soluble FGL-2 as innate-immune biomarkers in Iraqi patients with plaque psoriasis: a case-control study with diagnostic-performance evaluation

Return to Article Details Serum hBD-2, IL-36γ, CCL20/MIP-3α, and soluble FGL-2 as innate-immune biomarkers in Iraqi patients with plaque psoriasis: a case-control study with diagnostic-performance evaluation Download Download PDF